Leadership Overview
Sisram Medical has 5 executives leading key functions including finance, marketing, regional operations, human resources, and China-specific leadership.
Driven by a commitment to innovation, Sisram Medical is dedicated to enhancing consumer quality of life through advanced medical aesthetics, offering cutting-edge technologies across surgical, medical aesthetics, and beauty markets.
Driven by a commitment to innovation, Sisram Medical is dedicated to enhancing consumer quality of life through advanced medical aesthetics, offering cutting-edge technologies across surgical, medical aesthetics, and beauty markets.
Leadership Roles at Sisram Medical
Annie Camargo - Regional Chief Executive Officer
Annie Camargo, the Regional Chief Executive Officer at Sisram Medical, spearheads strategic initiatives and operational oversight for key geographic markets. Directing regional business development and performance, the Regional Chief Executive Officer ensures alignment with Sisram Medical's global objectives and fosters localized growth strategies. This leadership position involves managing diverse teams and optimizing operations to enhance service delivery and market presence within specific territories. By navigating regional market complexities and consumer demands, Annie Camargo drives the adoption of Sisram Medical's advanced technologies, including those for hair removal and skin rejuvenation. Camargo's focus on operational excellence and market expansion directly supports the company's mission to improve consumer quality of life through accessible and effective medical aesthetics. The Regional Chief Executive Officer's role is critical in translating global strategies into tangible regional success and strengthening Sisram Medical's footprint worldwide.
Jiahong Li - Chief Financial Officer
Jiahong Li, the Chief Financial Officer at Sisram Medical, directs all financial operations and strategic fiscal planning. Overseeing global financial health, the Chief Financial Officer ensures robust capital management and drives profitability across all business units. This leadership role involves optimizing resource allocation and managing investment portfolios to support Sisram Medical's expansion in the medical aesthetics sector. By analyzing market trends and financial performance, Jiahong Li provides critical insights that guide corporate strategy and operational efficiency. Li's expertise is vital for maintaining financial stability and fostering sustainable growth, directly impacting the company's ability to deliver innovative wellness solutions worldwide. The Chief Financial Officer's responsibilities extend to compliance, risk management, and stakeholder relations, ensuring transparency and accountability in all fiscal matters.
Yossi Azulay - President, Sisram (China)
Yossi Azulay, the President, Sisram (China) at Sisram Medical, leads the strategic direction and operational execution for the significant Chinese market. Directing all business activities within China, the President, Sisram (China) ensures the successful deployment of Sisram Medical's product portfolio, including hair removal and skin rejuvenation technologies. This executive role involves navigating the unique market dynamics and regulatory landscape of China to drive growth and expand consumer access to advanced medical aesthetics. By fostering strong local partnerships and understanding consumer needs, Yossi Azulay champions the company's mission to enhance quality of life through innovative wellness solutions. Azulay's leadership is key to strengthening Sisram Medical's presence and impact in one of the world's largest consumer markets. The President, Sisram (China) oversees sales, marketing, and operational functions tailored to regional demands.
Tal Rosen - Chief Marketing Officer
Tal Rosen, the Chief Marketing Officer at Sisram Medical, architects and executes comprehensive global marketing strategies. Overseeing brand development and market penetration, the Chief Marketing Officer drives consumer engagement and strengthens brand equity across Sisram Medical's diverse portfolio, including Alma, LMNT, and Copulla. This pivotal role involves identifying new market opportunities and translating consumer needs into effective product positioning and promotional campaigns. By analyzing market dynamics and competitive landscapes, Tal Rosen ensures that Sisram Medical's cutting-edge technologies reach and resonate with target audiences in the surgical, medical aesthetics, and beauty sectors. Rosen's leadership is instrumental in communicating the company's commitment to innovation, education, and safety, thereby enhancing its market impact and consumer trust. The Chief Marketing Officer's strategic vision fuels the company's mission to improve millions of lives through advanced wellness solutions.
Orit Segal - Chief People Officer
Orit Segal, the Chief People Officer at Sisram Medical, cultivates a high-performance culture and directs all human capital strategies. Overseeing talent acquisition, development, and employee engagement, the Chief People Officer ensures that Sisram Medical attracts and retains top talent essential for innovation and operational excellence. This critical role involves fostering an environment that supports the company's commitment to education and safety within the medical aesthetics industry. By championing employee well-being and professional growth, Orit Segal contributes directly to the company's ability to deliver cutting-edge technologies and services. Segal's leadership ensures that the workforce is equipped to meet the evolving demands of the global consumer wellness market. The Chief People Officer's strategic approach to human resources is fundamental to Sisram Medical's sustained success and its mission to enhance consumer quality of life through advanced aesthetic solutions.
Explore Leadership Teams in Manufacturing
At United Imaging, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers in the United States, and other parts of the world. Our U.S. R&D facility opened in 2013 in Houston and was further established as the U.S. headquarters in 2018 with our service team and commercial organization in place. With a cutting-edge digital portfolio and a mission of broader access to healthcare for all, we help drive industry progress and bold change.
Company Leadership KB
JX
XC
CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellence and close working relationships with our eye care professional customers, CooperVision has helped improve the vision of millions and become a trusted global leader in the contact lens industry. CooperVision designs and manufactures innovative, high quality contact lenses to meet a remarkably wide range of wearer needs. We conduct extensive ongoing research and development in optical science. And we collaborate closely with eye care professionals, who help us identify the evolving needs of contact lens wearers around the world.
Company Leadership JC
SR
CH
JW
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...
Company Leadership
WT
DR
DM
Sarnova, Inc. is a family of companies that distribute healthcare products in emergency medical services and acute care markets. The company was founded in 2008 and is headquartered in Dublin, Ohio.
Company Leadership SS
Frequently Asked Questions Regarding Sisram Medical Top Executives and Leadership Team
